In Libya, the HIV/AIDS epidemic is characterized by a low but concentrated prevalence among drug users. Additionally, political, economic and societal stigma has exacerbated health care system challenges for those suffering. However, recent programs funded by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO) have led to progress, contributing to a decline in the rate of infection to 0.07 from 0.13 between 2010 and 2019. Despite this progress, there are still significant challenges.

Historical Context and Challenges

Libya first saw the appearance of the disease in 1986 when a Factor VIII contamination affected 24 hemophilia patients. In 1998, a tragic outbreak affected 400 children in Benghazi Hospital. Before the revolution in spring 2011, UNAIDS reported that international development partners found it difficult to work systematically in Libya. Society did not openly discuss AIDS, nor did it consider it a health priority. New data confirmed that the situation in Libya was worse than what officials previously reported.

Despite the low and concentrated epidemic among drug users in Libya, societal challenges persist. The United States’s (U.S.) 2018 Country Report cites no available information on societal violence toward persons with HIV/AIDS. However, it does mention reports of the Libyan government denying persons with HIV/AIDS permission to marry.

Additionally, it reported instances of segregation of detainees suspected of having the disease from the rest of the population in overcrowded spaces. In these cases, these people were often the last to receive medical treatment. In Libya, there is no specific law prohibiting discrimination based on age, gender, sexual orientation or HIV-positive status.

Interventions and Programs

Various interventions and programs have been implemented to address HIV/AIDS in Libya. In 2012, UNAIDS recommended drug substitution treatment and harm reduction measures such as voluntary, confidential counseling and testing, as well as the prevention of sexual transmission of HIV among drug users. This approach, which was implemented, centered around respecting the rights of drug users and worked to reduce the stigmatization of HIV/AIDS.

Furthermore, the United Nations Office on Drugs and Crime (UNODC) relaunched the second phase of the HIV project in Libya, focusing on the HIV prevention program among people injecting drugs in prison settings. The then-Libyan government funded the project. However, it was suspended in 2011 due to security problems and resumed the following year. Additionally, in 2019, officials implemented a program to prevent mother-to-child transmission (PMTCT). However, ongoing internal conflict and the COVID-19 pandemic have hindered its effectiveness.

Collaboration with UNODC experts also led to an evaluation study on rehabilitation as a component of harm reduction. Trainers educated a group of medical assistants in communities with several committees such as Y-Peer and Libyan Red Crescent. These efforts aimed to support prevention and treatment initiatives at the community level.

Recent Efforts and Recommendations

Despite some progress, significant challenges remain in treating HIV/AIDS in Libya. In 2022, the WHO reported that although Antiretroviral therapy (ART) is free to all Libyan citizens, repeated stockouts have interrupted treatment and led to increasing numbers of people living with HIV being admitted to health facilities with advanced stages of the disease.

Additionally, only four of Libya’s eight ART centers are fully functioning and there are fewer than 10 HIV testing centers in the entire country. The stigma of HIV extends even to health care workers through their association with those who have HIV/AIDS due to misconceptions about the disease.

To improve the response to HIV/AIDS, the WHO has advocated for regular funding for the National Aids Program (NAP) and aligning its activities with the Regional Action Plan on HIV, hepatitis and sexually transmitted infections (STIs).

Final Remark

Continued international support, enhanced infrastructure for testing and robust anti-stigma campaigns are crucial for addressing the HIV/AIDS epidemic in Libya effectively. This could be achieved by collaborating with philanthropic organizations and foundations that focus on global health. By focusing on these areas, Libya can build a stronger, more inclusive response to the HIV/AIDS epidemic, ultimately improving health outcomes for all.

– Nia Willis

Nia is based in Carmarthenshire, UK and focuses on Global Health for The Borgen Project.

Photo: Flickr